8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

NEWBURYPORT, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported that net income increased 40% to $16.4 million in the third quarter of 2024 from $11.7 million in the third quarter of 2023. Sales for the third quarter increased 44% to $145.2 million compared to 2023 third quarter sales of $100.8 million. Net income increased 28% to $42.6 million for the nine-month period ended September 30, 2024 from $33.3 million in the same period of 2023. Sales for the nine-month period ended September 30,

NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies (UFPT), today announced Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Vice President and Chief Financial Officer, will present at the Midwest IDEAS Investor Conference on Wednesday, August 28, 2024 at The Gwen in Chicago, IL. UFP's presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/midwest and in the investor relations section of the company's website: http://www.ufpt.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues for qu

NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

NEWBURYPORT, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $13.6 million or $1.75 per diluted common share outstanding for its second quarter ended June 30, 2024, compared to net income of $11.9 million or $1.55 per diluted common share outstanding for the same quarter in 2023. Sales for the second quarter were $110.2 million compared to sales of $100.0 million in the second quarter of 2023. Net income for the six-month period ended June 30, 2024, was $26.2 million or $3.38 per diluted common sha

NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and C

NEWBURYPORT, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host 1 x 1 meetings at the upcoming CJS Securities 24th Annual New Ideas Summer Conference to be held on July 10, 2024 at the Metropolis Country Club in White Plains, NY. About UFP Technologies, Inc.UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly

NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems. "We are very excited to add AJR Enterprises' capabilities to our patient surfaces portfolio," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Patient surfaces and transfer devices are a growing market due

NEWBURYPORT, Mass., June 10, 2024 (GLOBE NEWSWIRE) --  UFP Technologies (UFPT), today announced that Jeffrey Bailly, Chairman & CEO, and Ron Lataille, Sr. Vice President & CFO, will present at the East Coast IDEAS Investor Conference on Wednesday, June 12, 2024, at Jay Conference – Bryant Park in New York, NY. UFP's presentation is scheduled to begin at 4:10 PM ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the company's website: http://www.UFPT.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional v

NEWBURYPORT, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $12.7 million or $1.64 per diluted common share outstanding for its first quarter ended March 31, 2024, compared to net income of $9.7 million or $1.27 per diluted common share outstanding for the first quarter of 2023. Net Sales for the first quarter were $105.0 million compared to 2023 first quarter sales of $97.8 million. "I am very pleased with our financial results and continued progress on a number of key strategic fronts," said R. Jeffrey Bailly, Chairman & CEO. "In Q1

NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and C

NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems. "We are very excited to add AJR Enterprises' capabilities to our patient surfaces portfolio," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Patient surfaces and transfer devices are a growing market due

NEWBURYPORT, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd. Founded in 1993 and headquartered in Galway, Ireland, with operations in Costa Rica and partner manufacturing in Mexico, Advant Medical is a developer and manufacturer of Class I, II, and III medical devices and packaging.    "We are pleased to be joining forces with Advant, our third major acquisition in six months," said R. Jeffrey Bailly, Chairman and CEO. "It's an excellent cultural and strategic fit that i

NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches. "Adding DAS Medical to the UFP MedTech portfolio is another important step in our growth strategy," said R. Jeffrey Bailly,

NEWBURYPORT, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Contech Medical, Inc. Founded in 1987 and headquartered in Providence, Rhode Island, with partner manufacturing in Costa Rica, Contech Medical is a global leader in the design, development, and manufacture of class III medical device packaging primarily for catheters and guidewires. Annual sales are approximately $18 million. "We are very pleased to add a new and differentiated medical technology to our growing portfolio," said R. 

Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

KeyBanc Capital Markets initiated coverage of UFP Technologies with a rating of Sector Weight

Lake Street resumed coverage of UFP Technologies with a rating of Buy and set a new price target of $124.00

Lake Street initiated coverage of UFP Technologies with a rating of Buy and set a new price target of $110.00

Colliers Securities initiated coverage of UFP Technologies with a rating of Buy and set a new price target of $81.00

NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company's MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer. "Mitch has been an extremely valuable member of our management team for over 25 years, most recently very successfully leading our MedTech group," said Bailly. "He is hard-working, well-known, and well-respected throughout our indust

Lake Street analyst Jaeson Schmidt maintains UFP Techs (NASDAQ:UFPT) with a Buy and raises the price target from $344 to $392.

Marble Medical Founded In 1988 And Headquartered In Tallahassee, FL

Lake Street analyst Jaeson Schmidt maintains UFP Techs (NASDAQ:UFPT) with a Buy and raises the price target from $300 to $344.

UFP Technologies, Inc. (NASDAQ:UFPT) shares are trading higher after the company disclosed the buyout of AJR Enterprises, LLC for $110 million. AJR Enterprises specializes in developing and manufacturing single-use safe patient handling systems and generated sales of approximately $70 million in 2023 and $75 million in the trailing 12-month period that ended in March. “We are very excited to add AJR Enterprises’ capabilities to our patient surfaces portfolio,” said R. Jeffrey Bailly, chairman and CEO of UFP Technologies.  UFP funded the transaction through borrowings under its amended and restated credit agreement. “Patient surfaces and transfer devices are a growing market due i

Lake Street analyst Jaeson Schmidt maintains UFP Techs (NASDAQ:UFPT) with a Buy and raises the price target from $270 to $300.

Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday's session as the company reported first-quarter results and issued revenue guidance for the second quarter. AMD guided to second-quarter revenue of $5.7 billion plus or minus $300 million and a non-GAAP gross margin of about 53% against Street estimates of $5.7 billion in second-quarter revenue. Street expectations for fiscal year 2024 are for earnings of $3.40 per share and revenue of $24.13 billion, respectively, according to data from Benzinga Pro. Advanced Micro Devices shares dipped 6.9% to $147.44 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers CytomX Th